Aspect Medical Systems
This article was originally published in The Gray Sheet
Aspect Medical Systems: Private round of financing led by The Hillman Company and T.Rowe Price Associates raises $11.7 mil.. Funds will be used to "accelerate market adoption" of the Natic, Massachusetts firm's Bispectral Index (BIS) anesthesia monitoring technology "and to establish the BIS as a standard for anesthetic monitoring," the firm states. Aspect received 510(k) clearance from FDA in October 1996 to promote BIS technology as a means to improve clinical outcomes and lower the cost of anesthesia care ("The Gray Sheet" Dec. 16, 1996, I&W-7)...
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.